Mateo Lendoire

Mateo Lendoire

Auto-generated profile, based on publicly available information

Mateo Lendoire

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
ABArtem Boyev
Artem Boyev
CTChing-Wei D Tzeng
Ching-Wei D Tzeng
HMHarufumi Maki
Harufumi Maki
EAElsa M. Arvide
Elsa M. Arvide
DMDeborah E. Mrema
Deborah E. Mrema
TNTimothy E. Newhook
Timothy E. Newhook

18 May 2023 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
HMHarufumi Maki
Harufumi Maki
AJAnish Jay Jain
Anish Jay Jain
AHAntony Haddad
Antony Haddad
MLMateo Lendoire
Mateo Lendoire
YCYun Shin Chun
Yun Shin Chun
JVJean-Nicolas Vauthey
Jean-Nicolas Vauthey
In patients with colorectal liver metastases (CLM), surgery is potentially curative. The use of novel surgical techniques and complementary percutaneous ablation allows for curative‐intent treatment even in marginally resectable cases. Resection is used as part of a multidisciplinary approach, which for nearly all patients will include perioperative chemotherapy. Small CLM can be treated with parenchymal‐sparing hepatectomy (PSH) and/or ablation. For small CLM, PSH results in better survival and higher rates of resectability of recurrent CLM than non‐PSH. For patients with extensive bilateral distribution of CLM, two‐stage hepatectomy or fast‐track two‐stage hepatectomy is effective. Our increasing knowledge of genetic alterations allows us to use them as prognostic factors alongside traditional risk factors (e.g. tumor diameter and tumor number) to select patients with CLM for resection and guide surveillance after resection. Alteration in RAS family genes (hereafter referred to as “RAS alteration”) is an important negative prognostic factor, as are alterations in the TP53, SMAD4, FBXW7, and BRAF genes. However, APC alteration appears to improve prognosis. RAS alteration, increased number and diameter of CLM, and primary lymph node metastasis are well‐known risk factors for recurrence after CLM resection. In patients free of recurrence 2 y after CLM resection, only RAS alteration is associated with recurrence. Thus, surveillance intensity can be stratified by RAS alteration status after 2 y. Novel diagnostic instruments and tools, such as circulating tumor DNA, may lead to further evolution of patient selection, prognostication, and treatment algorithms for CLM.

23 February 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
HMHarufumi Maki
Harufumi Maki
AHAntony Haddad
Antony Haddad
MLMateo Lendoire
Mateo Lendoire
TNTimothy E. Newhook
Timothy E. Newhook
OPOliver Peacock
Oliver Peacock
YYY. Nancy You
Y. Nancy You

7 May 2024 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
MLMateo Lendoire
Mateo Lendoire
HMHarufumi Maki
Harufumi Maki
AHAntony Haddad
Antony Haddad
TNTimothy E. Newhook
Timothy E. Newhook
CTChing-Wei D. Tzeng
Ching-Wei D. Tzeng
HCHop S Tran Cao
Hop S Tran Cao

1 December 2023 in Revista Argentina de Cirugia
Verified
Journal Article
Closed access
HAHospital Alemán de Buenos Aires. Buenos Aires. Argentina
Hospital Alemán de Buenos Aires. Buenos Aires. Argentina
MUMateo Lendoire de Undurraga
Mateo Lendoire de Undurraga
GWGabriel Weber
Gabriel Weber
CACristian A. Angeramo
Cristian A. Angeramo
PCPablo Capitanich
Pablo Capitanich
The incidence of isolated pulmonary metastases in pancreatic ductal adenocarcinoma is about 13%. Resection of these metastases is uncommon; however, patients presenting only with pulmonary metastases have better survival compared to those with metastases on other locations. We report the case of a female patient who underwent lobectomy for metastases from pancreatic ductal adenocarcinoma. After resection, disease-free interval and specific diseases-free survival were 84 and 152 moths, respectively. We consider that the next step in the treatment of this subpopulation of patients is to select those patients with favorable tumor biology who would benefit from a more aggressive approach.

30 December 2022 in Revista Argentina de Coloproctología
Verified
Journal Article
Closed access
ECEmiliano Caruso
Emiliano Caruso
MUMateo Lendoire de Undurraga
Mateo Lendoire de Undurraga
NRNicolás Agustín Rotholtz
Nicolás Agustín Rotholtz
MBMaximiliano Enrique Bun
Maximiliano Enrique Bun
El carcinoma de células escamosas (SCC) rectal primario es una enfermedad rara con solo unos pocos casos informados en la literatura. Se presenta el caso de un paciente de sexo femenino que cursa con carcinoma escamoso de recto tratado con readioquimio terapia.